Ocular Surface Disease Clinical Trials
3 recruiting trials for Ocular Surface Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Ocular Surface Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Lithuanian University of Health Sciences (1), Vienna Institute for Research in Ocular Surgery (1), Rinsada (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Artificial tears (sodium hyaluronate 0.2%) (device, 1 trial), followed by Eyelid closure for 3 minutes, Rinsada.
Track Ocular Surface Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Pattern of Dry Eye Disease After Cataract Surgery
This study is designed to explore dry eye disease (DED) pattern: ocular surface, corneal morphological changes, patients' subjective assessment of DED and their correlations with...
Eyelid Closure in Keratometry
Cataract surgery is one of the most common performed surgeries in the world. While in the early beginnings of cataract surgery, visual rehabilitation was the main goal of the...
The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease
The central hypothesis is that inflammation contributes to dry eye and that rinsing the palpebral conjunctiva, bulbar conjunctiva, and fornices will reduce the inflammatory burden...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Ocular Surface Disease, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Ocular Surface Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Ocular Surface Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.